HOLX inventory positive aspects amid constructive views from analysts on This fall outcomes (NASDAQ:HOLX)

Hologic, Inc. (NASDAQ:HOLX) gained ~7% pre-market Tuesday as analysts issued favorable views on the COVID-19 check developer’s This fall fiscal 2022 outcomes that exceeded the corporate forecasts and the consensus.

Hologic’s (HOLX) 2023 outlook which was in line with the consensus for income and adjusted earnings, “seems like a beat amidst decrease sentiment,” Raymond James analyst Andrew Cooper wrote with an Outperform score on the inventory.

“…in all probability, the information is a extra necessary issue and although optically bracketing consensus, it is a constructive consequence amidst extra unfavourable market-wide sentiment into the print,” Cooper added.

Cowen analyst Max Masucci who has the same score on Hologic (HOLX), wrote that the corporate “delivered a stable FQ4 beat from a development and profitability standpoint.”

Forward of the earnings replace, “we characterised HOLX inventory as a ‘comparatively secure place to be,’ given its stability sheet and upward revision potential,” Masucci famous, including, “Exiting the print, our opinion is unchanged.”

Heading into the corporate’s earnings outcomes, In search of Alpha contributor Shri Upadhyaya recognized Hologic (HOLX) as an underappreciated asset given its robust financials, historical past of enterprise execution, and promising outlook.